BR9506047A - Partículas montadas de um virus de planta vacina para proteção contra patógenos humanos ou animais vacina de virus de animal fragmento de cdna de proteína de revestimento de cpmv vetor transcrito de rna e processo para proteger animais (incluíndo humanos) contra patógenos - Google Patents

Partículas montadas de um virus de planta vacina para proteção contra patógenos humanos ou animais vacina de virus de animal fragmento de cdna de proteína de revestimento de cpmv vetor transcrito de rna e processo para proteger animais (incluíndo humanos) contra patógenos

Info

Publication number
BR9506047A
BR9506047A BR9506047A BR9506047A BR9506047A BR 9506047 A BR9506047 A BR 9506047A BR 9506047 A BR9506047 A BR 9506047A BR 9506047 A BR9506047 A BR 9506047A BR 9506047 A BR9506047 A BR 9506047A
Authority
BR
Brazil
Prior art keywords
animal
pathogens
vaccine
virus
coat protein
Prior art date
Application number
BR9506047A
Other languages
English (en)
Inventor
George Peter Lomonossoff
Original Assignee
Axis Genetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axis Genetics Ltd filed Critical Axis Genetics Ltd
Publication of BR9506047A publication Critical patent/BR9506047A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR9506047A 1994-07-13 1995-07-10 Partículas montadas de um virus de planta vacina para proteção contra patógenos humanos ou animais vacina de virus de animal fragmento de cdna de proteína de revestimento de cpmv vetor transcrito de rna e processo para proteger animais (incluíndo humanos) contra patógenos BR9506047A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414118A GB9414118D0 (en) 1994-07-13 1994-07-13 Modified plant viruses as vectors of heterologous peptides
PCT/GB1995/001618 WO1996002649A1 (en) 1994-07-13 1995-07-10 Modified plant viruses as vectors of heterologous peptides

Publications (1)

Publication Number Publication Date
BR9506047A true BR9506047A (pt) 1997-08-05

Family

ID=10758254

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506047A BR9506047A (pt) 1994-07-13 1995-07-10 Partículas montadas de um virus de planta vacina para proteção contra patógenos humanos ou animais vacina de virus de animal fragmento de cdna de proteína de revestimento de cpmv vetor transcrito de rna e processo para proteger animais (incluíndo humanos) contra patógenos

Country Status (16)

Country Link
US (1) US5958422A (pt)
EP (1) EP0719336B1 (pt)
JP (1) JP3681753B2 (pt)
KR (1) KR100379803B1 (pt)
CN (1) CN1211488C (pt)
AT (1) ATE346934T1 (pt)
AU (1) AU697867B2 (pt)
BR (1) BR9506047A (pt)
CA (1) CA2170412C (pt)
CZ (1) CZ290484B6 (pt)
DE (1) DE69535314T2 (pt)
GB (1) GB9414118D0 (pt)
HU (1) HU223078B1 (pt)
NZ (1) NZ289170A (pt)
SK (1) SK34296A3 (pt)
WO (1) WO1996002649A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977438A (en) * 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
US6846968B1 (en) 1988-02-26 2005-01-25 Large Scale Biology Corporation Production of lysosomal enzymes in plants by transient expression
US6660500B2 (en) 1988-02-26 2003-12-09 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
US7033835B1 (en) 1988-02-26 2006-04-25 Large Scale Biology Corporation Production of peptides in plants as viral coat protein fusions
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
US5484719A (en) 1991-08-26 1996-01-16 Edible Vaccines, Inc. Vaccines produced and administered through edible plants
US6034298A (en) * 1991-08-26 2000-03-07 Prodigene, Inc. Vaccines expressed in plants
WO1997010347A1 (en) * 1995-09-15 1997-03-20 Howard John A Expression cassettes and methods for delivery of animal vaccines
GB9712282D0 (en) * 1997-06-12 1997-08-13 Innes John Centre Innov Ltd Epitope presentation system
US6759243B2 (en) 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
GB9921337D0 (en) 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US7135282B1 (en) 1999-10-14 2006-11-14 The Dow Chemical Company Viral particles with exogenous internal epitopes
US6932980B1 (en) * 2001-01-18 2005-08-23 Richard Sayre Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition
AU2001269936A1 (en) * 2000-06-20 2002-01-02 Phycotransgenics, Llc Transgenic algae for delivering antigens to an animal
IL151882A0 (en) * 2001-01-24 2003-04-10 Virogene Ltd Vectors capable of imparting herbicide resistance and viral cross protection
US8101189B2 (en) * 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
MXPA05000287A (es) * 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
CN1926238A (zh) * 2004-02-27 2007-03-07 陶氏化学公司 植物细胞中的高效肽生产
WO2006124044A2 (en) * 2004-07-30 2006-11-23 George Mason University Protein scaffolds and viral particles for detecting analytes
WO2006093967A2 (en) * 2005-02-28 2006-09-08 The Scripps Research Institute Compositions and methods for targeting or imaging a tissue in a vertebrate subject
CN101287489A (zh) * 2005-06-01 2008-10-15 陶氏环球技术公司 多价病毒样颗粒的生产
CA2615658A1 (en) * 2005-07-19 2007-01-25 Dow Global Technolgies Inc. Recombinant flu vaccines
DK2069503T3 (da) * 2006-11-15 2016-02-15 Folia Biotech Inc Papayamosaikvirus-baserede vacciner mod influenza
ATE452978T1 (de) * 2007-01-03 2010-01-15 Academia Sinica Rekombinante virale proteine und partikel
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
NZ587108A (en) * 2007-11-27 2013-04-26 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
KR101745925B1 (ko) 2008-07-18 2017-06-12 메디카고 인코포레이티드 신규 인플루엔자 바이러스 면역화 에피토프
WO2010012069A1 (en) * 2008-07-30 2010-02-04 Folio Biotech Inc. Multivalent vaccines based on papaya mosaic virus and uses thereof
US20100183523A1 (en) 2009-01-22 2010-07-22 Wagner Richard E Dental composition and method
SI2445928T1 (en) 2009-06-24 2018-05-31 Medicago Inc. HYPER PARTICULARS, SIMILAR VIRUSES OF GRIPE, WHICH HAVE EXPOSED HEMAGLUTININE
SG178918A1 (en) 2009-09-22 2012-04-27 Medicago Inc Method of preparing plant-derived vlps
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
BR112016015875A2 (pt) 2014-01-10 2017-09-19 Medicago Inc Elementos intensificadores de cpmv
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10617751B2 (en) 2017-07-13 2020-04-14 VisionTech International Limited Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and humans

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8421282D0 (en) * 1984-08-22 1984-09-26 Connaught Lab Multispecific antigenic proteins
EP1013771B1 (en) * 1988-02-26 2004-10-06 Large Scale Biology Corporation Non-nuclear chromosomal transformation
WO1991013994A1 (en) * 1990-03-13 1991-09-19 Commonwealth Scientific And Industrial Research Organisation Gene expression
JPH05506145A (ja) * 1990-04-06 1993-09-16 コモンウエルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガニゼイション 修飾ポチウイルス外被タンパク質に基づく自己ポリマー化発現系
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors
ATE212671T1 (de) * 1991-08-01 2002-02-15 Large Scale Biology Corp Rekombinierte virale nukleinsäure aus pflanzen
WO1995021248A1 (en) * 1994-02-03 1995-08-10 The Scripps Research Institute Method for using tobacco mosaic virus to overproduce peptides and proteins

Also Published As

Publication number Publication date
SK34296A3 (en) 1996-07-03
WO1996002649A1 (en) 1996-02-01
JP3681753B2 (ja) 2005-08-10
EP0719336B1 (en) 2006-11-29
CZ290484B6 (cs) 2002-08-14
EP0719336A1 (en) 1996-07-03
GB9414118D0 (en) 1994-08-31
CZ72396A3 (en) 1996-06-12
DE69535314D1 (de) 2007-01-11
NZ289170A (en) 1997-11-24
AU697867B2 (en) 1998-10-22
ATE346934T1 (de) 2006-12-15
DE69535314T2 (de) 2007-03-08
HU223078B1 (hu) 2004-03-29
HUP9600586D0 (en) 1996-05-28
US5958422A (en) 1999-09-28
JPH09504961A (ja) 1997-05-20
CN1134174A (zh) 1996-10-23
CN1211488C (zh) 2005-07-20
AU2893495A (en) 1996-02-16
KR100379803B1 (ko) 2003-10-04
HUT75088A (en) 1997-04-28
CA2170412A1 (en) 1996-02-01
CA2170412C (en) 2010-01-12

Similar Documents

Publication Publication Date Title
DE69535314D1 (de) Modifizierte pflanzenviren als vektore für heterologe peptide
DE69731659D1 (de) Impfstoffzubereitung bestehend aus untereinheiten des respiratorischen synzytialvirus (rsv)
EP1854886A3 (en) Cold-adapted equine influenza viruses
EP0773295A3 (en) DNA-based vaccination of fish by immersion
DE69734284D1 (de) Zusammensetzung eines polynukleotidvakzins zur behandlung von atemwegs- und fortpflanzungsbezogenen erkrankungen des schweins
ATE266397T1 (de) Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
ES2110097T3 (es) Sistema de liberacion basado en proteinas.
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
FI973468A0 (fi) Hampaiden valkaisemiseen tai ihon ja limakalvojen sairauksien hoitoon käytettävien valmisteiden valmistusmenetelmä
EA199800746A1 (ru) Способ генерации противовирусного иммунного ответа у человека или животного
CA2399172A1 (en) Cold-adapted equine influenza viruses
PL324774A1 (en) Purified thermally, coagulated potato protein for use as a feed for animals
DE60125736D1 (de) Zusammensetzungen, die kälteangepasste pferdeinfluenzaviren enthaltende, für die behandlung von bestehende virusinfektionen des atmungssystems
ES2177535T3 (es) Vacunas contra protozoos intestinales.
MY101874A (en) Vaccine
DE69306934D1 (de) Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
DE60223564D1 (de) Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
BR9909076A (pt) Vìrus atenuado do sarampo, recombinantemente gerado, isolado, vìrus do sarampo, vìrus sincicial respiratório humano (rsv), subgrupo b, atenuado, recombinantemente gerado, isolado, o rsv, subgrupo b, vacina processo para imunização de um indivìduo para induzir proteção contra vìrus do sarampo, processo para imunização de um indivìduo para induzir proteção contra o rsv, subgrupo b, composição, processo para produção de vìrus do sarampo infeccioso atenuado, processo para produção de rsv infeccioso atenuado subgrupo b
GB9201013D0 (en) Vaccines
EP0839913A3 (en) DNA-Based vaccination of fish by immersion
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
RU94020597A (ru) Способ лечения псевдотуберкулеза
BR0012589A (pt) Proteìna recombinante, composição farmacêutica, composição de vacina, molécula de ácido nucleico, vetor, célula hospedeira, animal transgênico, uso de uma proteìna recombinante, processo para a formulação de uma composição farmacêutica, e, métodos para a prevenção ou tratamento de uma doença em um indivìduo, para preparar uma proteìna recombinante, e para vacinar um mamìfero contra uma doença ou de tratar um mamìfero sofrendo de uma doença
ATE276760T1 (de) Verfahren zur herstellung von autovakzinen zur behandlung von chlamydiosen von säugetieren und menschen

Legal Events

Date Code Title Description
PC Transfer

Free format text: GAC NO 39 LIMITED (GB)

TC Change of name
FA10 Dismissal: dismissal - article 33 of industrial property law
HKFN Application deemed withdrawn (deleted)
PC Transfer

Owner name: THE DOW CHEMICAL COMPANY (US)

TE Change of address
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: DOW GLOBAL TECHNOLOGIES INC. (US)

Free format text: TRANSFERIDO DE: THE DOW CHEMICAL COMPANY

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: COM BASE NO ART. 8 DA LPI NO9279/96 O PEDIDO DEVE SER INDEFERIDO.